Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population‐based study - Concepedia

Concepedia

Publication | Closed Access

Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population‐based study

30

Citations

11

References

2015

Year

Kaori Fujita, Miwako Nagasaka, Sota Iwatani, Tsubasa Koda, Daisuke Kurokawa, Keiji Yamana, Kosuke Nishida, Mariko Taniguchi‐Ikeda, Eiko Uchino, Chika Shirai,

Pediatrics International

Abstract

The prevalence of SGA and short stature in children born SGA who qualify for GH treatment is approximately 1 of 30 infants and 1 of 1800 children, respectively. The risk is increased when children are born <34 weeks GA.

References

	Year	Citations

Page 1